Flosonics Medical
Flosonics Medical is dedicated to improving patient care through innovative ultrasound technology. Their flagship product, FloPatch, is the first wireless, wearable Doppler ultrasound device designed to provide real-time hemodynamic assessments, enabling clinicians to make informed decisions regarding fluid resuscitation and management, particularly in critical care settings.
Flosonics Medical
Patents
Ultrasound patch with integrated flexible transducer assembly
2024-03-26 • US-11937976-B2
View DetailsWhat We Do
FloPatch is a wireless, wearable Doppler ultrasound device that provides real-time hemodynamic assessments to clinicians, helping them make precise and informed decisions on fluid resuscitation. It assesses the carotid arterial pulse in real-time, allowing for efficient, data-driven decisions in acute care settings.
Infectious Diseases
Diagnostics
Key People
CEO, Co-Founder
Chief Medical Officer, Co-Founder
VP of Operations, Co-Founder
VP of Engineering
VP of Sales
News & Updates
Flosonics Medical and Lovell Government Services have partnered to serve federal healthcare systems, providing access to FloPatch, the first wearable Doppler ultrasound for critical care.
Flosonics Medical was awarded Best in Class in the Digital Health Awards for its development of FloPatch, recognizing its impact on patient care in critical situations.
Sutter Health has implemented FloPatch in its ICUs to improve patient care and safety, particularly for those with sepsis and septic shock.
Flosonics Medical announced its Series C financing, raising $20 million to support the growth and market adoption of FloPatch.
Flosonics Medical was selected as Best in Class in the Digital Health Awards for its development of FloPatch, recognizing its commitment to improving outcomes for critically ill patients.